Company Filing History:
Years Active: 1985-1989
Title: Innovations of Steven D Wyrick
Introduction
Steven D Wyrick is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as hypolipidemic agents. With a total of four patents to his name, Wyrick's work has the potential to impact the treatment of lipid-related health issues.
Latest Patents
Wyrick's latest patents include innovative compounds such as N,N-diaminophthalamides. This compound has a specific structural formula and demonstrates utility as a hypolipidemic agent. The invention also outlines a process for controlling lipidemia in mammals by administering an effective amount of the compound. Another significant patent is for 2,3-dihydrophthalazine-1,4-diones, which also serves as a hypolipidemic agent. This patent details a process for controlling hyperlipidemia in mammals and includes a pharmaceutical composition that incorporates the compound along with a pharmaceutically acceptable carrier.
Career Highlights
Wyrick is associated with Research Incorporated, where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a focus on compounds that can effectively manage lipid levels in mammals, showcasing his commitment to advancing medical science.
Collaborations
Some of Wyrick's notable coworkers include Iris H Hall and James M Chapman, Jr. Their collaboration likely enhances the innovative environment at Research Incorporated, fostering the development of new ideas and solutions.
Conclusion
Steven D Wyrick's contributions to the field of pharmaceuticals through his patents highlight his role as a significant inventor. His work in developing hypolipidemic agents demonstrates the potential for innovation in medical treatments.